← Back to Screener
Illumina Inc (ILMN)
Price$132.72
Favorite Metrics
Price vs S&P 500 (26W)31.28%
Price vs S&P 500 (4W)1.75%
Market Capitalization$20.08B
P/E Ratio (Annual)23.62x
All Metrics
P/CF (Annual)18.61x
Book Value / Share (Quarterly)$17.80
P/TBV (Annual)8.18x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-1.78%
Cash Flow / Share (Quarterly)$6.08
Price vs S&P 500 (YTD)-1.80%
Gross Margin (TTM)66.61%
Net Profit Margin (TTM)19.57%
EPS (TTM)$5.48
10-Day Avg Trading Volume1.39M
EPS Excl Extra (TTM)$5.48
Revenue Growth (5Y)6.04%
EPS (Annual)$5.45
ROI (Annual)18.04%
Gross Margin (Annual)66.08%
Net Profit Margin (5Y Avg)-22.68%
Cash / Share (Quarterly)$10.67
P/E Basic Excl Extra (TTM)23.62x
Revenue Growth QoQ (YoY)4.98%
EPS Growth (5Y)4.22%
P/E Normalized (Annual)23.62x
ROA (Last FY)12.79%
Revenue Growth TTM (YoY)-0.66%
EBITD / Share (TTM)$8.63
ROE (5Y Avg)-20.04%
Operating Margin (TTM)18.44%
Cash Flow / Share (Annual)$6.08
P/B Ratio7.37x
P/B Ratio (Quarterly)7.55x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)4.76x
Net Interest Coverage (TTM)-2.28x
ROA (TTM)13.55%
EPS Growth QoQ (YoY)85.61%
EV / EBITDA (TTM)15.37x
EPS Incl Extra (Annual)$5.45
Current Ratio (Annual)2.08x
Quick Ratio (Quarterly)1.58x
3-Month Avg Trading Volume1.87M
52-Week Price Return76.21%
EV / Free Cash Flow (Annual)22.18x
P/E Incl Extra (TTM)23.62x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$16.42
P/S Ratio (Annual)4.62x
Asset Turnover (Annual)0.65x
52-Week High$155.53
Operating Margin (5Y Avg)-23.62%
EPS Excl Extra (Annual)$5.45
CapEx CAGR (5Y)-4.77%
Tangible BV CAGR (5Y)-11.20%
26-Week Price Return35.26%
Quick Ratio (Annual)1.58x
13-Week Price Return-9.13%
Total Debt / Equity (Annual)0.73x
Current Ratio (Quarterly)2.08x
Enterprise Value$20,651.355
Revenue / Share Growth (5Y)4.93%
Asset Turnover (TTM)0.69x
Book Value / Share Growth (5Y)-11.15%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.65x
Pretax Margin (Annual)25.01%
Cash / Share (Annual)$10.67
3-Month Return Std Dev43.29%
Gross Margin (5Y Avg)65.39%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)2.69%
EBITDA Interim CAGR (5Y)5.75%
ROE (Last FY)31.22%
Net Interest Coverage (Annual)20.38x
EPS Basic Excl Extra (Annual)$5.45
P/FCF (TTM)21.57x
Receivables Turnover (TTM)5.34x
EV / Free Cash Flow (TTM)22.18x
Total Debt / Equity (Quarterly)0.73x
EPS Incl Extra (TTM)$5.48
Receivables Turnover (Annual)5.34x
ROI (TTM)19.22%
P/S Ratio (TTM)4.62x
Pretax Margin (5Y Avg)-20.36%
Revenue / Share (Annual)$27.84
Tangible BV / Share (Annual)$16.42
Forward P/E25.91x
Free OCF CAGR (5Y)0.88%
Price vs S&P 500 (52W)46.38%
P/E Ratio (TTM)23.62x
Year-to-Date Return0.84%
5-Day Price Return6.95%
EPS Normalized (Annual)$5.45
ROA (5Y Avg)-9.81%
Net Profit Margin (Annual)19.57%
Month-to-Date Return7.30%
Cash Flow / Share (TTM)$-4.41
EBITD / Share (Annual)$5.67
Operating Margin (Annual)18.58%
LT Debt / Equity (Annual)0.55x
P/CF (TTM)18.61x
ROI (5Y Avg)-13.42%
P/E Excl Extra (TTM)23.62x
LT Debt / Equity (Quarterly)0.55x
EPS Basic Excl Extra (TTM)$5.48
P/TBV (Quarterly)8.18x
P/B Ratio (Annual)7.55x
Inventory Turnover (TTM)2.61x
Pretax Margin (TTM)24.98%
Book Value / Share (Annual)$17.80
Price vs S&P 500 (13W)-9.82%
Net Margin Growth (5Y)-0.68%
Beta1.49x
P/FCF (Annual)21.57x
Revenue / Share (TTM)$28.39
ROE (TTM)34.94%
52-Week Low$69.83
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.67
3.62
3.68
3.68
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ILMNIllumina Inc | 4.62x | 6.04% | 66.61% | 18.44% | $132.72 |
AAgilent Technologies Inc. | 4.74x | 5.41% | 52.60% | 20.40% | $118.25 |
WATWaters Corp | 10.04x | 6.00% | 59.28% | 25.36% | $319.04 |
MTDMettler-Toledo International | 6.50x | 5.47% | 59.37% | 26.05% | $1290.84 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $89.53 |
BIOBio-Rad Laboratories, Inc.Class A | 3.06x | 0.29% | 52.01% | 1.59% | $291.09 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.06x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.75x | 11.57% | 47.13% | 1.40% | $306.06 |
BRKRBruker Corporation | 1.73x | 11.57% | 47.13% | 1.40% | $38.94 |
AVTRAvantor, Inc. | 0.86x | 0.49% | 32.65% | -3.83% | $8.26 |
TXG10x Genomics, Inc. Class A Common Stock | 5.04x | 16.56% | 69.13% | -9.49% | $25.24 |
About
Illumina is a leading provider of genetic analysis tools and services for life science and clinical applications. The company derives over 90% of revenue from sequencing instruments, consumables, and related services, offering both high-throughput whole genome sequencing and targeted solutions for viral and cancer detection. Illumina also operates a microarray business (9% of 2024 revenue) serving consumer genomics and agricultural markets with more cost-effective genetic screening options.